The present invention relates to modified ADAMTS4 proteins having improved stability comparing to the corresponding native, unmodified proteins. The modified ADAMTS4 proteins can be expressed and isolated in large quantities, thus allowing further characterization of the proteins, such as crystallographic and enzyme kinetic studies. The purified, stable proteins would also facilitate the production of anti-ADAMTS antibodies and the development of inhibitors to ADAMTS enzymes.

 
Web www.patentalert.com

< Extendible stent apparatus

< Kits for screening for blood coagulation disorders

> Method of reducing analysis time of endpoint-type reaction profiles

> Human anti-factor IX/IXa antibodies

~ 00294